Skip to main content

Table 2 Clinical variables for the 38 leprosy patients broken down according to aPL antibody positivity or negativity at the sera collected in 2010/2011

From: Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy

Variables

Serum aPL (2010/2011 collected sera)

p-value

Negative

Positive

Total

N

%

n

%

N

%

Vascular Thrombosis

1*

 No

6

100.0%

31

96.9%

37

97.4%

 Yes

0

0.0%

1

3.1%

1

2.6%

Pregnancy Morbidity

1*

 No

6

100.0%

31

96.9%

37

97.4%

 Yes

0

0.0%

1

3.1%

1

2.6%

Diabetes

1*

 No

6

100.0%

30

93.8%

36

94.7%

 Yes

0

0.0%

2

6.3%

2

5.3%

Smoking

0.670*

 No

3

50.0%

20

62.5%

23

60.5%

 Yes

3

50.0%

12

37.5%

15

29.5%

Alcoholism

0.315*

 No

5

83.3%

31

96.9%

36

94.7%

 Yes

1

16.7%

1

3.1%

2

5.3%

  1. *Chi-square test